Explore Plasminogen Activator Inhibitors
Assaying α2-AP activity may be useful in case of α2-AP deficiency or during fibrinolytic therapy.
-
BIOPHEN™ α2-Antiplasmin LRTLiquid and Ready to use
Determination of α2-Antiplasmin (α2-AP) activity, in human citrated plasma, in liquid format.
Reference Registration Presentation 220502 CE-IVD R1: 3 x 3 mL
R2: 3 x 3 mL
No description for this category
-
ZYMUTEST™ PAI-1 Activity
Measurement of the activity of human Tissue-Plasminogen Activator Inhibitor, type I (PAI-1), in plasma, or in any fluid where active PAI-1 can be present, by Bio-Immuno-Assay.
Reference Registration Presentation RK019A RUO 96 tests -
ZYMUTEST™ PAI-1 Antigen
Measurement of human Tissue- Plasminogen Activator Inhibitor, type I (PAI-1) in plasma, or in any fluid where PAI-1: Ag can be present, by Elisa.
Reference Registration Presentation RK012A CE-IVD 96 tests
No description for this category
-
ZYMUTEST™ (Total) TAFI :Ag
Measurement of human Total TAFI (Thrombin Activatable Fibrinolysis Inhibitor) antigen forms in plasma, or in any fluid where Total TAFI can be present. Zymogen, as well as inactive forms are measured, by Elisa.
Reference Registration Presentation RK008A
on-demandRUO 96 tests -
ZYMUTEST™ (Activatable) TAFI
Measurement of human TAFI (Thrombin Activatable Fibrinolysis Inhibitor) zymogen and fully activatable (or CPU), in plasma, or in any fluid where human TAFI zymogen can be present. Inactive forms of TAFI are measured, by Elisa.
Reference Registration Presentation RK037A
on-demandRUO 96 tests